fbpx
Mississippi medical cannabis industry to launch July 1

Mississippi medical cannabis industry to launch July 1

Mississippi medical cannabis legalization

After months of lengthy legal battles, legislation effectively legalizing cannabis for medicinal use in Mississippi will become law on July 1, 2022. The Mississippi Department of Revenue will be running the licensing process.

The agency has said that it will begin accepting applications for dispensaries starting July 5. Patients and medical practitioners will be able to begin applying for applications and registrations on July 1, along with some cannabis production licenses. These licenses specifically will be handled by the Mississippi Department of Health (MSDOH).

Both agencies’ responsibilities stem from the Mississippi Medical Cannabis Act (MMCA), which was passed in February of this year. Medical cannabis legalization was delayed by nearly a year in the state after a voter initiative to legalize, Initiative 65, was overturned by the Mississippi Supreme Court in May of 2021.

Now patients with conditions covered under the MMCA can go to their physician and complete a medical certification from the MSDOH. If approved, patients will be able to apply to join the medical cannabis program. Once accepted they will receive patient ID they can use to purchase cannabis from a licensed dispensary.

While patients may be accepted as early as next month, plants won’t go in the ground in Mississippi until the bill is officially law, i.e. July 1. With dispensary applications being accepted starting July 5, it will certainly be several months before we see any dispensaries open with cannabis product on their shelves.

Estimates claim that purchasing could begin by December this year, or January 2023.

For those seeking a license, the state plans to hand them out within 30 days of receiving a completed application, meaning dispensary construction could begin within the next two months. The state is also accepting applications for a variety of other medical cannabis industry licenses:

  • Cultivator/Grower

  • Processor/Wholesaler

  • Transporter (local freight)

  • Transporter (long distance)

  • Testing Facility

  • Waste Disposal

Mississippi medical marijuana legalized by Governor

Mississippi medical marijuana legalized by Governor

mississippi medical marijuana legalized

Mississippi is legalizing medical marijuana for people with debilitating conditions such as cancer, AIDS and sickle cell disease.

Republican Gov. Tate Reeves signed the legislation Wednesday and it became law immediately. It could be months before the first marijuana dispensaries open.

“There is no doubt that there are individuals in our state who could do significantly better if they had access to medically prescribed doses of cannabis,” Reeves wrote in a statement posted to Twitter. “There are also those who really want a recreational marijuana program that could lead to more people smoking and less people working, with all the societal and family ills that that brings.”

The National Conference of State Legislatures says 36 states and four territories already allowed the medical use of cannabis. Mississippi becomes the 37th state.

“For all the people who are touched in some way by a loved one or someone they know who benefits from medical cannabis, this brings their quality of life back,” said Ken Newburger, executive director the Mississippi Medical Marijuana Association, a group that pushed for legalization.

A majority of Mississippi voters approved a medical marijuana initiative in November 2020, and it would have allowed people to buy up to 5 ounces a month. The state Supreme Court invalidated it six months later by ruling that the state’s initiative process was outdated and the measure was not put properly on the ballot.

The state House and Senate, both controlled by Republicans, passed the final version of Senate Bill 2095 last week.

The new law will allow patients to buy up to to 3.5 grams of cannabis per day, up to six days a week. That is about 3 ounces per month. It sets taxes on production and sale of cannabis, and it specifies that plants must be grown indoors under controlled conditions.

Mississippi medical marijuana bill introduced

Mississippi medical marijuana bill introduced

mississippi medical marijuana bill introduced into state senate

After months of debate and back-and-forth, lawmakers in Mississippi have finally produced a bill to implement a new medical cannabis law in the state.​

After months of speculation and hand-wringing, the Mississippi Legislature is set to take up a medical marijuana bill in the Senate as soon as Thursday, lawmakers said.

Sen. Kevin Blackwell, R-Southaven, filed the long-awaited bill late Tuesday afternoon. Lt. Gov. Delbert Hosemann referred the 445-page bill to the Senate Public Health and Welfare Committee for review.

Wednesday afternoon, the bill was passed by the Senate public health committee. Should it pass the Senate, it would head to the House and then to the governor.

Speaker of the House Philip Gunn said at the start of the legislative session medical marijuana was not a top priority of his. Bryan’s committee held two hearings over the summer about what a proposed medical marijuana bill would look like in Mississippi.

Gov. Tate Reeves said in June 2021 he would call a special session of the legislature if the House and Senate could agree on a bill.

In September, Gunn and Hosemann announced their two chambers had reached an agreement, but Reeves never called a session, objecting to portions of the bill. A draft version was made public in September, and lawmakers worked to address most of Reeves concerns.

Study Finds Cannabis Compounds Prevent Infection By Covid-19 Virus

Study Finds Cannabis Compounds Prevent Infection By Covid-19 Virus

cannabis can help with covid-19

Compounds in cannabis can prevent infection from the virus that causes Covid-19 by blocking its entry into cells, according to a study published this week by researchers affiliated with Oregon State University.

A report on the research, “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants,” was published online on Monday by the Journal of Natural Products.

The researchers found that two cannabinoid acids commonly found in hemp varietals of cannabis, cannabigerolic acid, or CBGA, and cannabidiolic acid, also known as CBDA, can bind to the spike protein of SARS-CoV-2, the virus that causes Covid-19. By binding to the spike protein, the compounds can prevent the virus from entering cells and causing infection, potentially offering new avenues to prevent and treat the disease.

“Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the potential to prevent as well as treat infection by SARS-CoV-2,” the researchers wrote in an abstract of the study.

The study was led by Richard van Breemen, a researcher with Oregon State’s Global Hemp Innovation Center in the College of Pharmacy and Linus Pauling Institute, in collaboration with scientists at the Oregon Health & Science University. Van Breeman said that the cannabinoids studied are common and readily available.

“These cannabinoid acids are abundant in hemp and in many hemp extracts,” van Breemen said, as quoted by local media. “They are not controlled substances like THC, the psychoactive ingredient in marijuana, and have a good safety profile in humans.”

Cannabinoids Effective Against New Variants

Van Breemen added that CBDA and CBGA blocked the action of emerging variants of the virus that causes Covid-19, saying that “our research showed the hemp compounds were equally effective against variants of SARS-CoV-2, including variant B.1.1.7, which was first detected in the United Kingdom, and variant B.1.351, first detected in South Africa.”

Colombian Medical Cannabis Will Be Covered By Insurance

Colombian Medical Cannabis Will Be Covered By Insurance

Colombian medical cannabis

Khiron Life Sciences Corp., a vertically integrated medical cannabis leader with core operations in Latin America, announced on January 4th that the Government of Colombia has added medical cannabis to its list of mandated covered medications for every insurance provider in the country.

Khiron became the first licensed distributor of Colombian medical cannabis in March 2020. The company has currently sold 57,000 prescriptions, with over 16,000 patients across the country.

The plans to mandate insurance coverage for medical cannabis was implemented in December 2020, and throughout 2021 Khiron has been working with insurance providers across Colombia to include their medical cannabis in their coverage. In 2021, 60% of medical cannabis sales done by Khiron were through insurance providers.

The inclusion of medical cannabis in insurance coverage has greatly increased the number of prescribed patients as well as patient retention as medical cannabis becomes more easily accessible and more affordable through insurance.

Additionally, starting in 2022 any Colombian can get their medical cannabis card nearly for free, regardless of their insurance. These new implementations will make Colombia one of the only, and also the leading cannabis provider through insurance in the world.

The implications of having one sole provider of medical cannabis for the entire country of Colombia are yet to be seen. Whether there will be more space for competition in the future is also unknown.